Nadia Passini

Vir Biotechnology (Switzerland) — Switzerland

Immunology and Microbiology · Life Sciences

13h-index1.8kcitations28works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammation biomarkers and pathways(8), Immune Cell Function and Interaction(6), T-cell and B-cell Immunology(4), Diabetes and associated disorders(4), Hepatitis C virus research(3)

Publications28 total

Increased breadth and neutralization of antibodies against SARS-CoV-2 variants after infection and vaccination: A serosurveillance study in pediatric patients of Southern Switzerland
European Journal of Pediatrics·2024
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
Journal of Hepatology·2023· 46 citedOpen Access
The potent broadly neutralizing antibody VIR-3434 controls Hepatitis B and D Virus infection and reduces HBsAg in humanized mice
2022· 2 citedOpen Access
Pre-clinical characterization of an HBsAg-specific monoclonal antibody preventing HBV spreading and reducing HBV, HDV and HBsAg in serum of humanized mice
Zeitschrift für Gastroenterologie·2022
1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
Open Forum Infectious Diseases·2020· 4 citedOpen Access
Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
Journal of Infection and Public Health·2016· 41 citedOpen Access
Abstract 2568: Application of novel phospholipid conjugated Toll like receptor 7 ligands for cancer therapy by topical and systemic administration
Cancer Research·2014· 1 cited
Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effects
European Journal of Dermatology·2013· 9 citedOpen Access
BASIC AND TRANSLATIONAL—ALIMENTARY TRACT Bacterial Sensor Triggering Receptor Expressed on Myeloid Cells-2 Regulates the Mucosal Inflammatory Response
2013
Bacterial Sensor Triggering Receptor Expressed on Myeloid Cells-2 Regulates the Mucosal Inflammatory Response
Gastroenterology·2012· 61 citedOpen Access
847u The Bacterial Sensor Triggering Receptor Expressed on Myeloid Cells 2 (TREM-2) is a Crucial Pathogenic Mediator in Inflammatory Bowel Disease (IBD)
Gastroenterology·2010
The surface‐exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor
Journal of Neurochemistry·2009· 148 cited
The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. J Neurochem
2009· 1 cited
Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
Brain·2008· 306 citedOpen Access
84 Epigenetic Control of Human Th1 Cell Differentiation
Cytokine·2007
Chromatin remodeling by the SWI/SNF‐like BAF complex and STAT4 activation synergistically induce IL‐12Rβ2 expression during human Th1 cell differentiation
The EMBO Journal·2007· 78 citedOpen Access
Calcitriol derivatives with two different side chains at C-20
The Journal of Steroid Biochemistry and Molecular Biology·2007· 20 cited
Modulation of the Triggering Receptor Expressed on the Myeloid Cell Type 1 Pathway in Murine Septic Shock
Infection and Immunity·2006· 112 citedOpen Access
EXPRESSION OF TREM-1 LIGAND ON NEUTROPHILS PROVIDES A POTENTIAL DIAGNOSTIC TOOL IN SEPSIS.
Shock·2004· 3 cited
Proliferative responses to selected peptides of IA‐2 in identical twins discordant for Type 1 diabetes
Diabetes/Metabolism Research and Reviews·2000
page 1 of 2Next →

Frequent Co-authors

Lars Rogge(9), Francesco Sinigaglia(8), Paola Panina‐Bordignon(8), Davide Corti(6), Fabio Benigni(5), Mauro Biffi(4), Carmen Correale(3), Stefania Vetrano(3), Chiara Martinoli(3), Antonino Spinelli(3), Vincenzo Arena(3), Flavio Caprioli(3), Silvio Danese(3), Florian A. Lempp(3), Tassilo Volz(3), Elisabetta Cameroni(3), Fabrizia Zatta(3), Siro Bianchi(3), Leah Soriaga(3), Christy M. Hebner(3)